Leader of multi-disciplinary clinical operations organization (clinical trial management, data management, monitoring, medical writing and biostatistics), responsible for clinical trial quality and delivery across AskBio's portfolio of gene therapy development.

Executive leader responsible for clinical project management and project delivery across all phases of drug development and in all of Alexion’s rare disease therapy areas, which include hematology, metabolics, neuroscience and nephrology.

Head of US Site Management and Monitoring for Phase I through III programs. I led a group of 280 people, both regionally and headquarters-based, who were responsible for site selection, contracting, start-up, eTMF and CTMS maintenance, monitoring and project leadership. Led the transition to an in-house monitoring group in 2017 and proud recipient of the Society for Clinical Research Sites Eagle Award in 2018. Additional contributions have included leading late-phase, full-service outsourcing, development and implementation of the late-phase sourcing strategy and implementation of risk-based quality management for the enterprise.

Development Operations Therapy Area Lead for Pain and Regenerative Medicine, supporting both early and late-phase development units as their single point of accountability and managing a group of program-aligned Clinical Operations Program Leads.Previous assignments at Pfizer have included:- Development and Clinical Alliance Management Asset Group Lead- Clinical Project Management Business Unit Director (Specialty Care)- Clinical Project Management Group Lead for inflammation and ophthalmology- Clinical Operations lead for neuroscience development- Worldwide Project Management site head- Development Operations Team Lead for Phase 3 alliance project- Head of site-based data management group